Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: The protective effect

Human Immunology

Volumn 64, Issue 10, 2003, Pages 930-935

  Gibert, Morgane ^a,c   Balandraud, Nathalie ^b,d   Touinssi, Mhammed ^c   Mercier, Pierre ^c   Roudier, Jean ^b,d   Reviron, Denis ^b,c  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b INSERM   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

Author keywords

France; Functional; HLA class II; Rheumatoid arthritis; Shared epitope

Indexed keywords

EPITOPE; HLA DR ANTIGEN;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FRANCE; GENETIC CODE; GENOTYPE; HUMAN; HYBRIDIZATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; PROTECTION; PROTEIN BINDING; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS;

EID: 0141642052     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(03)00186-1     Document Type: Article

References (21)

1. Gregersen PK, Silver J, Winchester RJ: The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205, 1987.
2. Reveille JD: The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 10:187, 1998.
3. Wordsworth BP, Pile K, Buckely J, Lanchbury J, Ollier B, Lathrop M, Bell JI: HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 51:585, 1992.
4. Jawaheer D, Thomson W, MacGregor AJ, Carthy D, Davidson J, Dyer PA, Silman AJ, Ollier WE: "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 37:681, 1994.
5. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215, 1994.
6. Reviron D, Perdriger A, Toussirot E, Wendling D, Balandraud N, Guis S, Semana G, Tiberghien P, Mercier P, Roudier J: Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis Rheum 44:535, 2001.
7. Ou D, Mitchell LA, Tingle AJ: A new categorization of HLA DR alleles on a functional basis. Hum Immunol 59:665, 1998.
8. Olson RR, De Magistris MT, Di Tommaso A, Karr RW: Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide. J Immunol 148:2703, 1992.
9. Fu XT, Bono CP, Woulfe SL, Swearingen C, Summers NL, Sinigaglia F, Sette A, Schwartz BD, Karr RW: Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide. J Exp Med 181:915, 1995.
10. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315, 1988.
11. Charron D, Fauchet R: Twelfth International Histocompatibility Workshop reference protocol Addendum 12-1994. In Charron D (ed): Genetic Diversity of HLA: Functional and Medical Implication. Paris: EDK, 1997 Volume 1.
12. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR- SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225, 1992.
13. Haldane J: The estimation and significance of the logarithm of a ratio frequencies. Ann Hum Genet 20:309, 1995.
14. Mattey DL, Dawes PT, Gonzales-Gay MA, Garcia-Porrua C, Thomson W, Hajeer AH, Ollier W: HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. J Rheumatol 28:232, 2001.
15. Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigaglia F: Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 181:1847, 1995.
16. Woulfe SL, Bono CP, Zacheis ML, Kirschmann DA, Baudino TA, Swearingen C, Karr RW, Schwartz BD: Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401. Arthritis Rheum 38:1744, 1995.
17. Sanchez B, Moreno I, Magarino R, Garzon M, Gonzalez MF, Garcia A, Nunez-Roldan A: HLA-DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population. Tissue Antigens 36:174, 1990.
18. Yelamos J, Garcia-Lozano JR, Moreno I, Aguilera I, Gonzalez MF, Garcia A, Nunez-Roldan A, Sanchez B: Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum 36:811, 1993.
19. Wakitani S, Murata N, Toda Y, Ogawa R, Kaneshige T, Nishimura Y, Ochi T: The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese. Br J Rheumatol 36:630, 1997.
20. de Vries N, Tijssen H, van Riel PL, van de Putte LB: Reshaping the shared epitope analysis. HLA associated risk to rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of HLA-DRB1 molecule. Arthritis Rheum 46:921, 2002.
21. Hughes AL, Yeager M, Carrington M: Peptide binding function and the paradox of HLA disease associations. Immunol Cell Biol 74:444, 1996.